Interleukin-6 induces drug resistance in renal cell carcinoma

Metastatic renal cell carcinoma (mRCC) is a tumor entity with poor prognosis due to limited therapy options. Tyrosine kinase inhibitors (TKIs), the novel targeted agents have been used for the treatment of mRCC and have shown efficacy. Interferon (IFN)-α is also one of the most frequently used agent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Fukushima J Med Sci
Main Authors: Ishibashi, Kei, Koguchi, Tomoyuki, Matsuoka, Kanako, Onagi, Akifumi, Tanji, Ryo, Takinami-Honda, Ruriko, Hoshi, Seiji, Onoda, Mitsutaka, Kurimura, Yoshimasa, Hata, Junya, Sato, Yuichi, Kataoka, Masao, Ogawsa, Soichiro, Haga, Nobuhiro, Kojima, Yoshiyuki
Formato: Artigo
Idioma:Inglês
Publicado em: The Fukushima Society of Medical Science 2018
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6305783/
https://ncbi.nlm.nih.gov/pubmed/30369518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5387/fms.2018-15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados